Back
Galectin Therapeutics Stock Predictions
Sponsored
GALT
Sponsored
"This Changes Everything" - Trump Hands Millions Massive IRS Gift
Learn More Here
Sell
40
GALT
Galectin Therapeutics
Last Price:
2.75
Seasonality Move:
14%
7 Day Trial
ALL ACCESS PASS
$
7
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.Galectin Therapeutics Stock Forecast
-
Is Galectin Therapeutics Stock Undervalued?
The current Galectin Therapeutics [GALT] share price is $2.69. The Score for GALT is 40, which is 20% below its historic median score of 50, and infers higher risk than normal. - GALT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Galectin Therapeutics Stock Go Up Next Year?
Data Unavailable
Galectin Therapeutics Stock Rating
Data Unavailable
Galectin Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
galectintherapeutics.com
52-Week Data
52-Week High:
4.27
52-Week Low:
1.56
Prediction Charts
Market Cap:
168.83M
Price in USD:
2.69
Volume:
174.03K
Beta:
1.18
Technical Analysis
SMA50:
2.69
SMA100:
2.53
SMA200:
2.58
52-Wk Change:
37.24%
Stock Predictions
-
Is Galectin Therapeutics stock public?
Yes, Galectin Therapeutics is a publicly traded company. -
What is the Galectin Therapeutics stock quote today?
The Galectin Therapeutics stock price is 2.69 USD today. -
How to buy Galectin Therapeutics stock online?
You can buy Galectin Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Oct-30 | 2.55 | 2.52 | 2.65 | 2.51 |
Oct-31 | 2.50 | 2.47 | 2.57 | 2.45 |
Nov-1 | 2.51 | 2.50 | 2.58 | 2.45 |
Nov-4 | 2.46 | 2.53 | 2.60 | 2.46 |
Nov-5 | 2.55 | 2.61 | 2.62 | 2.52 |
Nov-6 | 2.80 | 2.81 | 2.85 | 2.67 |
Nov-7 | 2.78 | 2.84 | 2.89 | 2.76 |
Nov-8 | 2.85 | 3.00 | 3.05 | 2.82 |
Nov-11 | 3.17 | 2.89 | 3.17 | 2.85 |
Nov-12 | 2.89 | 2.95 | 3.02 | 2.89 |
Nov-13 | 2.96 | 2.91 | 3.04 | 2.82 |
Nov-14 | 2.86 | 2.75 | 2.95 | 2.75 |
Nov-15 | 2.80 | 2.77 | 2.88 | 2.66 |
Nov-18 | 2.77 | 2.69 | 2.85 | 2.65 |
Galectin Therapeutics Earnings
Data Unavailable
Galectin Therapeutics Forecast Revenue Growth
Data Unavailable
* Galectin Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.